Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Grows By 485.4%

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totaling 116,151 shares, an increase of 485.4% from the May 31st total of 19,840 shares. Based on an average daily trading volume, of 284,099 shares, the days-to-cover ratio is presently 0.4 days.

Siemens Healthineers Stock Performance

OTCMKTS SMMNY opened at $19.44 on Friday. The stock’s 50 day simple moving average is $20.23 and its 200-day simple moving average is $22.88. Siemens Healthineers has a 1-year low of $19.32 and a 1-year high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. The firm had revenue of $6.68 billion for the quarter, compared to analysts’ expectations of $6.96 billion.

Analysts Set New Price Targets

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.